FDA approves MiSight® 1 day so contact lens specifically designed to slow the progression of nearsightedness in children aged 8-12 at the initiation of treatment1† Read Article
MiSight® 1 day 6-year clinical trial results Read Article
MiSight® 1 day 3-year clinical trial results Read Article